Access

Article


Nature Medicine 12, 1390 - 1396 (2006)
Published online: 19 November 2006 | doi:10.1038/nm1485

Activation of bold beta2-adrenergic receptor stimulates big gamma-secretase activity and accelerates amyloid plaque formation

Yanxiang Ni1,3, Xiaohui Zhao1,3, Guobin Bao1, Lin Zou1, Lin Teng1, Zhu Wang1, Min Song2, Jiaxiang Xiong2, Yun Bai2 & Gang Pei1


Amyloid plaque is the hallmark and primary cause of Alzheimer disease. Mutations of presenilin-1, the gamma-secretase catalytic subunit, can affect amyloid-beta (Abeta) production and Alzheimer disease pathogenesis. However, it is largely unknown whether and how gamma-secretase activity and amyloid plaque formation are regulated by environmental factors such as stress, which is mediated by receptors including beta2-adrenergic receptor (beta2-AR). Here we report that activation of beta2-AR enhanced gamma-secretase activity and thus Abeta production. This enhancement involved the association of beta2-AR with presenilin-1 and required agonist-induced endocytosis of beta2-AR and subsequent trafficking of gamma-secretase to late endosomes and lysosomes, where Abeta production was elevated. Similar effects were observed after activation of delta-opioid receptor. Furthermore, chronic treatment with beta2-AR agonists increased cerebral amyloid plaques in an Alzheimer disease mouse model. Thus, beta2-AR activation can stimulate gamma-secretase activity and amyloid plaque formation, which suggests that abnormal activation of beta2-AR might contribute to Abeta accumulation in Alzheimer disease pathogenesis.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Alzheimer protease hitches a ride

Nature Medicine News and Views (01 Dec 2006)

The synaptic Aβ hypothesis of Alzheimer disease

Nature Neuroscience News and Views (01 Aug 2005)

See all 14 matches for News And Views